Garofalo Health Care S.p.A
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and n… Read more
Garofalo Health Care S.p.A (GHC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.060x
Based on the latest financial reports, Garofalo Health Care S.p.A (GHC) has a cash flow conversion efficiency ratio of 0.060x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€20.82 Million) by net assets (€348.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Garofalo Health Care S.p.A - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Garofalo Health Care S.p.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Garofalo Health Care S.p.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Garofalo Health Care S.p.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIMILARWEB LTD IS-01
F:63X
|
N/A |
|
1Stdibs.Com Inc
NASDAQ:DIBS
|
0.046x |
|
Genome & Company
KQ:314130
|
-0.065x |
|
Karyopharm Therapeutics Inc
NASDAQ:KPTI
|
0.022x |
|
Guangdong Jushen Logistics Co Ltd
SHE:001202
|
-0.042x |
|
Zeda Ltd.
JSE:ZZD
|
0.374x |
|
MITSUBISHI STEEL MFG
F:0BK
|
N/A |
|
Sidetrade
PA:ALBFR
|
0.086x |
Annual Cash Flow Conversion Efficiency for Garofalo Health Care S.p.A (2016–2024)
The table below shows the annual cash flow conversion efficiency of Garofalo Health Care S.p.A from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €333.14 Million | €34.99 Million | 0.105x | -36.80% |
| 2023-12-31 | €300.89 Million | €50.01 Million | 0.166x | +5.76% |
| 2022-12-31 | €279.15 Million | €43.87 Million | 0.157x | +12.83% |
| 2021-12-31 | €260.71 Million | €36.31 Million | 0.139x | +23.27% |
| 2020-12-31 | €203.22 Million | €22.96 Million | 0.113x | +14.67% |
| 2019-12-31 | €192.03 Million | €18.92 Million | 0.099x | -1.10% |
| 2018-12-31 | €185.85 Million | €18.52 Million | 0.100x | -62.13% |
| 2017-12-31 | €101.88 Million | €26.80 Million | 0.263x | +68.52% |
| 2016-12-31 | €79.12 Million | €12.35 Million | 0.156x | -- |